Apollo Hospitals Enterprise Limited
APOLLOHOSP
Classement en actions
#1776
Apollo Hospitals Enterprise Limited, through its group entities, delivers a... Apollo Hospitals Enterprise Limited, through its group entities, delivers a comprehensive range of medical services both within India and across international borders. Its medical infrastructure spans primary, secondary, and tertiary levels of care. Within its tertiary hospitals, advanced medical treatments are available, specializing in fields such as cardiology, cancer treatment (oncology), neurology, orthopedics, urgent care, robotic surgical procedures, and organ transplantation. Beyond direct patient care, the company extends its offerings to include project advisory services, health coverage solutions, the operation of medical educational institutions, an e-learning platform called Medvarsity, and research initiatives. Furthermore, its operations encompass retail pharmacies, foundational primary care clinics, maternity and specialized birthing centers, focused single-specialty clinics, general primary health centers, diagnostic lab networks, dental clinics, as well as daycare and in-home healthcare services. The company's extensive presence is marked by 9,911 hospital beds, 4,529 pharmacies, and 1,734 retail healthcare centers nationwide. This is complemented by its digital ventures: Apollo 24/7, a comprehensive omni-channel healthcare platform, and www.apollopharmacy, its online pharmaceutical retail outlet. Established in 1979, Apollo Hospitals Enterprise Limited maintains its corporate headquarters in Chennai, India.
Prix de l'action
$83.93
Capitalisation boursière
$12.07B
Changement (1 jour)
-1.23%
Changement (1 an)
-7.79%
Pays
IN
Échange Apollo Hospitals Enterprise Limited (APOLLOHOSP)
Catégorie
Healthcare
Ratio P/E pour Apollo Hospitals Enterprise Limited (APOLLOHOSP)
Ratio P/E au October 2026 TTM : 54.65
Selon les derniers rapports financiers et le cours de l'action de Apollo Hospitals Enterprise Limited, le ratio P/E actuel (TTM) est de 54.65. À la fin de l’année 2024, le P/E de l’entreprise était de 103.32.
Historique du ratio P/E pour Apollo Hospitals Enterprise Limited de 2005 à 2026
Ratio P/E à la fin de chaque année
| Année | Ratio P/E | Changez |
|---|---|---|
| 2026 (TTM) | 54.65 | -17.13% |
| 2025 | 65.95 | -36.17% |
| 2024 | 103.32 | 36.54% |
| 2023 | 75.67 | 23.02% |
| 2022 | 61.51 | -77.23% |
| 2021 | 270.18 | 675.57% |
| 2020 | 34.84 | -53.44% |
| 2019 | 74.82 | -42.50% |
| 2018 | 130.12 | 77.39% |
| 2017 | 73.35 | 28.30% |
| 2016 | 57.17 | -0.79% |
| 2015 | 57.63 | 38.45% |
| 2014 | 41.62 | 7.29% |
| 2013 | 38.80 | -1.09% |
| 2012 | 39.22 | 17.57% |
| 2011 | 33.36 | -0.96% |
| 2010 | 33.68 | 26.51% |
| 2009 | 26.63 | -18.22% |
| 2008 | 32.56 | 15.08% |
| 2007 | 28.29 | -44.09% |
| 2006 | 50.60 | 26.17% |
| 2005 | 40.10 | 0.00% |
Ratio P/E pour des entreprises similaires ou concurrentes
| Entreprise | P/E Ratio | Différence du P/E Ratio | Pays |
|---|---|---|---|
| 15.70 | -71.27% |
US
|
|
| - | - |
DE
|
|
| 10.40 | -80.97% |
US
|
|
| 32.07 | -41.32% |
SA
|
|
| 20.00 | -63.40% |
BR
|
Comment lire un P/E ratio ?
Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.
Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.
Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.